Phathom Pharmaceuticals, Inc. (PHAT)
11.25
-0.09
(-0.79%)
USD |
NASDAQ |
Apr 06, 16:00
11.26
+0.01
(+0.09%)
After-Hours: 20:00
Phathom Pharmaceuticals SG&A Expense (TTM) : 279.72M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Replimune Group, Inc. | 103.07M |
| ANI Pharmaceuticals, Inc. | 317.74M |
| MannKind Corp. | 229.86M |
| Ocugen, Inc. | 27.58M |
| Vanda Pharmaceuticals, Inc. | 237.95M |